药学流行病学的核心概念:新用户设计
Qoua L Her1, Julie Rouette2, Jessica C Young3
1Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Pharmacoepidemiology and drug safety
|November 25, 2024
概括
药理流行病学使用新用户研究设计来比较药物的安全性和有效性. 本综述详细介绍了三种设计:新用户与非用户,主动比较新用户 (ACNU) 和流行新用户 (PNU) 进行强大的临床试验模拟.
科学领域:
- 药学流行病学 药学流行病学
- 药物安全和有效性研究研究药物安全和有效性研究
- 临床试验设计模拟临床试验设计模拟
背景情况:
- 新用户的比较在药理流行病学中至关重要,以了解现实世界的药物效应.
- 现有的方法往往缺乏统一的框架,导致研究设计和解释不一致.
- 目标试验框架提供了一个标准化的方法来模拟使用观察数据的随机对照试验.
研究的目的:
- 审查药物流行病学新用户比较背后的历史背景和理由.
- 介绍和描述三个不同的新用户研究设计:新用户与非用户,主动比较新用户 (ACNU) 和流行新用户 (PNU).
- 讨论这些设计如何解决关键问题,例如定义"零时间",选择适当的比较器,以及管理偏差来源.
主要方法:
- 审查历史文献和关键概念在药物流行病学研究设计.
- 三个主要新用户研究设计的描述和分类.
- 应用临床示例 (激素替代疗法和冠心病风险) 来说明实际考虑.
主要成果:
- 目标试验框架为新用户研究设计提供了一个统一的结构.
- 每个设计 (新用户与非用户,ACNU,PNU) 在偏差控制和适用性方面都有特定的优点和局限性.
- 定义"零时间"和选择合适的比较组对于有效的研究执行至关重要.
结论:
- 提出的三个新用户研究设计为模拟药物流行病学目标试验提供了不同的方法.
- 仔细考虑零时定义,比较器选择和潜在偏差对于每个设计都至关重要.
- 这些设计有助于更严格和可解释的药物流行病学研究,增强药物安全性和有效性评估.
更多相关视频
20:24Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
Published on: January 31, 2014
16.5K
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.6K
相关概念视频
01:12Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
01:20Study Designs in Epidemiology
182
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
182
01:26Introduction to Epidemiology
650
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
650
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
01:28Structure-Activity Relationships and Drug Design
595
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
595
01:19Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773